Cytological and Subcellular Response of Cells Exposed to the Type-1 RIP Curcin and its Hemocompatibility Analysis

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Mohamed, M Sheikh ^a   Veeranarayanan, Srivani ^a   Minegishi, Hiroaki ^a   Sakamoto, Yasushi ^b   Shimane, Yasuhiro ^a   Nagaoka, Yutaka ^a   Aki, Atsushi ^a   Poulose, Aby Cheruvathoor ^a   Echigo, Akinobu ^a   Yoshida, Yasuhiko ^a   Maekawa, Toru ^a   Kumar, D Sakthi ^a  

^a TOYO UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84926340225     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05747     Document Type: Article

References (57)

1. Stirpe, F., Barbieri, L., Battelli, M. G., Soria, M. & Lappi, D. A. Ribosome- Inactivating Proteins from Plants: Present Status and Future Prospects. Nat. Biotechnol. 10, 405-412 (1992).
2. Stripe, F. Ribosome-inactivating proteins: From toxins to useful proteins. Toxicon 67, 12-16 (2013).
3. Barbieri, L., Battelli, M. & Stripe, F. Ribosome-inactivating proteins from plants. Biochim. Biophys. Acta 1154, 237-282 (1993).
4. Endo, Y., Mitsui, K., Motizuki, M. & Tsurugi, K. Themechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. J. Biol. Chem. 262, 5908-5912 (1978).
5. Endo, Y. & Tsurugi, K. RNA N-glycosidase activity of ricin A-chain, mechanism of action of the toxic lectin on eukaryotic ribosomes. J. Biol. Chem. 262, 8128-8130 (1987).
6. Stripe, F. Ribosome-inactivating proteins. Toxicon 44, 371-383 (2004).
7. Barbieri, L., Ferreras, J. M., Barraco, A., Ricci, P. & Stirpe, F. Some ribosome-inactivating proteins depurinate ribosomal RNA at multiple sites. Biochem. J. 286, 1-4 (1992).
8. Stirpe, F. & Battelli, M. G. Ribosome-inactivating proteins: progress and problems. Cell. Mol. Life Sci. 63, 1850-1866 (2006).
9. Ng, T. B., Chan, W. Y. & Yeung, H. W. Proteins with abortifacient, ribosome inactivating, immunomodulatory, antitumor and anti-AIDS activities from cucurbitaceae plants. Gen. Pharmac. 23, 575-590 (1992).
10. Lin, J. Y., Tserng, K. Y., Chen, C. C., Lin, L. T. & Tung, T. C. Abrin and ricin: new anti-tumour substances. Nature 227, 292-293 (1970).
11. Kanellos, J., McKenzie, I. F. & Pietersz, G. A. Intratumour therapy of solid tumours with ricin-antibody conjugates. Immunol. Cell Biol. 67, 89-99 (1989).
12. Ramakrishnan, S., Fryxell, D., Mohanraj, D., Olson, M. & Li, B. Cytotoxic conjugates containing translational inhibitory proteins. Ann. Rev. Pharmacol. Toxicol. 32, 579-621 (1992).
13. Xia, H. C., Li, F., Li, Z. & Zhang, Z. C. Purification and characterization of Moschatin, a novel type I ribosome-inactivating protein from the mature seeds of pumpkin (Cucurbita moschata), and preparation of its immunotoxin against human melanoma cells. Cell Research 13, 369-374 (2003).
14. Daniels1, T. R. et al. Conjugation of an anti-transferrin receptor IgG3-avidin fusion protein with biotinylated saporin results in significant enhancement of its cytotoxicity against malignant hematopoietic cells. Mol. Cancer Ther. 6, 2995-3008 (2007).
15. Pirie, C. M., Liu, D. V. & Wittrup, K. D. Targeted cytolysins synergistically potentiate cytoplasmic delivery of gelonin immunotoxin. Mol. Cancer Ther. 12, 1774-82 (2013).
16. Ghetie, M. A.&Vitetta, E. S. Recent developments in immunotoxin therapy. Curr. Opin. Immunol. 6, 707-714 (1994).
17. Narayanan, S., Surendranath, K., Bora, N., Surolia, A. & Karande, A. A. Ribosome inactivating proteins and apoptosis. FEBS Letters 579, 1324-1331 (2005).
18. Bolognesi, A.et al. Induction of apoptosis by ribosome-inactivating proteins and related immunotoxins. Int. J. Cancer 68, 349-355 (1996).
19. Sikriwal, D., Ghosh, P. & Batra, J. K. Ribosome inactivating protein saporin induces apoptosis through mitochondrial cascade, independent of translation inhibition. Int. J. Biochem. Cell Biol. 40, 2880-2888 (2008).
20. Cheung, M. C. et al. An evolved ribosome-inactivating protein targets and kills human melanoma cells in vitro and in vivo. Molecular Cancer 9, 28 (2010).
21. Xiong, S. D. et al. Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells. Int. J. Cancer 125, 774-782 (2009).
22. Thomas, R., Sah, N. K. & Sharma, P. B. Therapeutic biology of Jatropha curcas: a mini review. Curr. Pharm. Biotechnol. 9, 315-24 (2008).
23. Pandey, V. C. et al. Jatropha curcas: A potential biofuel plant for sustainable environmental development. Renewable and Sustainable Energy Reviews 16, 2870-2883 (2012).
24. Debnath, M. & Bisen, P. S. Jatropha curcas L., amultipurpose stress resistant plant with a potential for ethnomedicine and renewable energy. Curr. Pharm. Biotechnol. 9, 288-306 (2008).
25. Felke, J. The poisonous principles of the seeds of Jatropha curcas Linn. Landw. Versuchsw. 82, 427-430 (1914).
26. Juan, L., Fang, Y., Lin, T. & Fang, C. Antitumor effects of curcin from seeds of Jatropha curcas. Acta Pharmacol. Sin. 24, 241-246 (2003).
27. Lin, J. et al. Cloning and expression of curcin, a ribosome-inactivating protein from the seeds of Jatropha curcas. Acta Bot. Sin. 45, 858-863 (2003).
28. Qin, W., Ming-Xing, H., Ying, X., Xin-Shen, Z. & Fang, C. Expression of a ribosome inactivating protein (curcin 2) in Jatropha curcas is induced by stress. J. Biosci. 30, 351-357 (2005).
29. Zheng, Q. et al. Expression of curcin-transferrin receptor binding peptide fusion protein and its anti-tumor activity. Protein Expr Purif. 89, 181-188 (2013).
30. Mohamed, M. S. et al. Type 1 ribotoxin-curcin conjugated biogenic gold nanoparticles for a multimodal therapeutic approach towards brain cancer. Biochim Biophys Acta. (2013) http://dx.doi.org/10.1016/j.bbagen.2013.12.020.
31. Mishra, B. B. & Tiwari, V. K. Natural products: an evolving role in future drug discovery. Eur. J. Med. Chem. 46, 4769-807 (2011).
32. Mondal, S. et al. Natural products: promising resources for cancer drug discovery. Anticancer Agents Med Chem. 12, 49-75 (2012).
33. Luo, M. J. et al. Expression, purification and anti-tumor activity of curcin. Acta Biochim. Biophys. Sin. (Shanghai). 38, 663-668 (2006).
34. Zhao, Q., Wang, W., Wang, Y., Xu, Y. & Chen, F. The effect of curcin from Jatropha curcas on apoptosis of mouse sarcoma-180 cells. Fitoterapia 83, 849-852 (2012).
35. Lin, J., Yan, F., Tang, L. & Chen, F. Antitumor effects of curcin from seeds of Jatropha curcas. Acta Pharmacol. Sin. 24, 241-246 (2003).
36. Zheng, Q. et al. Expression of curcin-transferrin receptor binding peptide fusion protein and its anti-tumor activity. Protein Expr. Purif. 89, 181-188 (2013).
37. Kroemer, G. et al. Classification of cell death: recommendations of the nomenclature committee on cell death. Cell. Death Differ. 16, 3-11 (2009).
38. Guimarães, C. A. & Linden, R. Programmed cell deaths. Apoptosis and alternative deathstyles. Eur. J. Biochem. 271, 1638-1650 (2004).
39. Pyrko, P. et al. Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo. Mol. Cancer 5, 19 (2006).
40. Altieri, D. C. et al. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene, 22, 8581-8589 (2003).
41. Pennati, M. et al. Ribozyme-mediated down-regula-tion of survivin expression sensitizes human melanoma cells to topotecan in vitro and in vivo. Carcinogenesis 25, 1129-1136 (2004).
42. Green, D. R. & Kroemer, G. The pathophysiology of mitochondrial cell death. Science 305, 626-629 (2004).
43. Bottone, M. G. et al. Morphological Features of Organelles during Apoptosis: An Overview. Cells 2, 294-305 (2013).
44. Morgan, M. J. & Liu, Z. Crosstalk of reactive oxygen species and NF-κB signaling. Cell Research 21, 103-115 (2011).
45. Bae, Y. S., Oh, H., Rhee, S. G. & Do, Y. Y. Regulation of reactive oxygen species generation incell signaling. Molecules and Cells 32, 491-509 (2011).
46. Wan, F. & Lenardo, M. J. The nuclear signaling of NF-kappaB: current knowledge, new insights, and future perspectives. Cell Research 20, 24-33 (2010).
47. Rojo, F. et al. Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer. Ann. Oncol. 23, 1156-1164 (2012).
48. Kummar, S. et al. Advances in using PARP inhibitors to treat cancer. BMC Med. 10, 25 (2012).
49. Núñez, R., Sancho-Martínez, S. M., Novoa, J. M. & López-Hernández, F. J. Apoptotic volume decrease as a geometric determinant for cell dismantling into apoptotic bodies. Cell Death Differ. 17, 1665-1671 (2010).
50. Ono, S. Mechanism of depolymerization and severing of actin filaments and its significance in cytoskeletal dynamics. Int. Rev. Cytol. 258, 1-82 (2007).
51. Grashoff, C. Measuring mechanical tension across vinculin reveals regula-tion of focal adhesion dynamics. Nature 466, 263-266 (2010).
52. Thievessen, I. et al. Vinculin-actin interaction couples actin retrograde flow to focal adhesions, but is dispensable for focal adhesion growth. J Cell Biol. 202, 163-177 (2013).
53. Scott, B. C. et al. Lipoic and dihydrolipoic acids as antioxidants. A critical evaluation. Free Radic. Res. 20, 119-133 (1994).
54. Katsu, T., Ninomiya, C. & Kuroko, M. Action mechanism of amphipathic peptides gramicidin S and melittin on erythrocyte membrane. Biochim. Biophys. Acta 939, 57-63 (1988).
55. Grunkemeier, J. M., Tsai, W. B. & Horbett, T. A. Hemocompatibility of treated polystyrene substrates: contact activation, platelet adhesion, and procoagulant activity of adherent platelets. J. Biomed. Mater. Res. 41, 657-670 (1998).
56. Motlagh, D., Yang, J., Lui, K. Y., Webb, A. R. & Ameer, G. A. Hemocompatibility evaluation of poly(glycerol-sebacate) in vitro for vascular tissue engineering. Biomaterials 24, 4315-4324 (2006).
57. Tamada, Y., Kulik, E. A. & Ikada, Y. Simple method for platelet counting. Biomaterials 16, 259-261 (1995).